Skip to main content
. 2017 May 23;55(6):1698–1706. doi: 10.1128/JCM.02407-16

TABLE 3.

Results of two-tiered algorithms tested

Sample (no.) No. positive (%)
Two-tiered testinga,b
Two-EIA algorithms (MTTT)
LYT-ViraStripe STTT LYM/LYG-ViraStripe STTT C6-ViraStripe STTT LYT-C6 LYM/LYG-C6c
Lyme disease (124)
    Early Lyme disease with EM
        Acute (40) 19 (48) 17 (43) 17 (43) 20 (50) 22 (55)
        Convalescent (38) 24 (63) 23 (61) 24 (63) 30 (79) 29 (76)
    Lyme neuroborreliosis or Lyme carditis
        Lyme neuroborreliosis (10) 8 (80) 9 (90) 9 (90) 9 (90) 10 (100)
        Lyme carditis (7) 7 (100) 7 (100) 6 (86) 6 (86) 6 (86)
    Late Lyme disease, Lyme arthritis (29) 28 (97) 28 (97) 28 (97) 29 (100) 29 (100)
    All Lyme disease 86 (69) 84 (68) 84 (68) 94 (76) 96 (77)
Negative controls (347)
    Other diseases (144)
        Fibromyalgia (31) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
        Severe periodontitis (20) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
        Rheumatoid arthritis (21) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
        Syphilis (20) 0 (0) 0 (0) 0 (0) 2 (10) 1 (5)
        Multiple sclerosis (22) 0 (0) 0 (0) 0 (0) 1 (5) 0 (0)
        Infectious mononucleosis (30) 8 (27) 5 (17) 2 (7) 2 (7) 1 (3)
        All other diseases 8 (6) 5 (3) 2 (1) 5 (3) 2 (1)
    Healthy controls (203)
        Endemicd (101) 3 (3) 5 (5) 1 (1) 1 (1) 1 (1)
        Nonendemicd (102) 1 (1) 1 (1) 0 (0) 0 (0) 1 (1)
        All healthy controls 4 (2) 6 (3) 1 (0) 1 (0) 2 (1)
    All negative controls 12 (3) 11 (3) 3 (1) 6 (2) 4 (1)
a

ViraStripe immunoblots were read using a densitometer.

b

A ≤30-day duration-of-illness cutoff was applied for IgM Western immunoblotting.

c

The same results were obtained whether or not the ≤30-day duration-of-illness cutoff was applied to the LYM EIA.

d

Endemic and nonendemic are as defined in the footnotes to Table 1.